Treatment with TNX-102 SL (CBP SL) Produces Clinically Meaningful Improvements in Patient-Centered Outcomes in Fibromyalgia
Pharmacokinetic Characterization of Tonmya® (TNX-102 SL), a Sublingual Formulation of Cyclobenzaprine (CBP SL) for the Treatment of Adults with Fibromyalgia
Tonmya® (TNX-102 SL; CBP SL) Steady-State Pharmacokinetics Compared to Oral Simulations
